Healthcare Worker Shortage; Trump Clashes With Big Pharma; Surprise Billing
Houston, TX, Miami, FL, and Baton Rouge, LA, are three of the many cities battling repercussions from the COVID-19 coronavirus pandemic. Most daunting is the perpetuated shortage of healthcare workers as the pandemic continues to ravage the United States.
- Read more about Healthcare Worker Shortage; Trump Clashes With Big Pharma; Surprise Billing
- Add new comment
FDA Approves Atezolizumab for BRAF V600 Unresectable or Metastatic Melanoma
On July 30, 2020, the U.S. Food and Drug Administration (FDA) approved atezolizumab (Tecentriq®) in combination with cobimetinib and vemurafenib for patients with BRAF V600 mutation-positive unresectable or metastatic melanoma.
- Read more about FDA Approves Atezolizumab for BRAF V600 Unresectable or Metastatic Melanoma
- Add new comment
We Can’t Touch Each Other, But We Can Still Touch Lives
Since the COVID-19 coronavirus stay-at-home orders were issued in March 2020, the future has been difficult to imagine. National professional meetings, including ONS Congress, graduations, weddings, funerals, and other events that mark the transition from present to future were canceled. Creative, alternative ways to mark a transition to the future are highlighted on social media and the nightly news. Virtual, Zoom, and the new normal are standard verbiage in our conversations.
ONS Earns Awards for Publications and Periodicals
The Oncology Nursing Society’s (ONS’s) books, journals, and news magazine have a long history of industry recognition, receiving numerous awards for their commitment to excellence in publishing. This month, Association Media and Publishing, Association Trends, and Communication Concepts, Inc., added new distinctions to the ONS publishing portfolio.
What’s Working and What Isn’t in Telemedicine
Half of all healthcare professionals have started using telemedicine in response to the COVID-19 coronavirus pandemic. Patients and providers are trying to adjust to such rapid changes in the provision of health care. Providers want to know how to get reimbursement for telemedicine visits. Society is working together to answer the critical questions about this next wave of health care.
If You’re Trying to Be Productive, Stop Multitasking
When it comes to the human brain, the ability to effectively multitask is a myth. Although computers can run two or more programs simultaneously, our brains must task-switch, and in the transfer of attention, time and productivity are lost. Monotasking, or single tasking, is now considered a way to increase productivity and actually maximize time.
Antihistamines May Improve Survival From Malignant Melanoma
Users of two common antihistamines—desloratadine and loratadine—have lower mortality rates from cutaneous malignant melanoma than patients who use other antihistamines, researchers reported in Allergy.
Trump Uses Executive Orders to Lower Drug Pricing
As one of the only not-entirely-pandemic-related health policy topics currently in policymakers’ discussions, lawmakers are again revisiting the high cost of prescription drugs. Voters have voiced concerns in the current economic climate, and, eager to appease in the months before the November presidential election, the Trump administration responded.
Oncology Drug Reference Sheet: Enfortumab Vedotin-Ejfv
Enfortumab vedotin-ejfv (Padcev™) was granted accelerated approval in December 2019 for adults with locally advanced or metastatic urothelial cancer who previously received an immune checkpoint inhibitor (PD-1 or PD-L1 inhibitor) and platinum-containing therapy.
Nurse-Turned-Policymaker; Prescription Drug Reform; Safer Working Conditions
As one of the youngest members of the 2018 freshman congressional class, U.S. Representative Lauren Underwood (D-IL) has already made quite a name for herself. Eschewing, for the most part in this heightened environment, partisanship and instead concentrating on health and economic issues, the representative champions access and affordability for all Americans.